skip to main content

    Updated Visitor Guidelines

 

MENU

 

Head and Neck Cancer

How Immune Cells Could Guide Head and Neck Cancer Treatment Decisions

For patients with head and neck cancer, responses to treatment vary. Some do well with a combination of chemotherapy and radiation. Others have better outcomes with surgery. The question for clinicians is how to make the right choice before treatment. New evidence suggests a patient’s immune system may be a deciding factor.

Combination of traditional chemotherapy, new drug kills rare cancer cells in mice

An experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.

How to Maintain Weight During Cancer Treatment

It’s important to include enough carbohydrates, protein and fat in your meals to maintain weight during treatments because too much weight loss can actually slow down/delay treatment. But, side effects of treatment, including loss of appetite, can make it challenging to eat enough food to get the calories your body needs.

Up in Smoke Men and Lung Cancer

Men face a very high risk of lung cancer. It is the third leading cause of death, right behind prostate and colon cancer. Overall, lung cancer is also the third most common cancer and the leading cause of cancer deaths in the United States. The best thing a man -- or anyone -- can do to reduce this risk is to quit smoking or never start.

The best treatment for laryngeal cancer? This approach helps decide

After a decade of using a novel approach to select patients for laryngeal cancer treatment, researchers are reporting "exceptional" survival rates nearing 80 percent, even for the most advanced patients.

Predicting throat cancer recurrence with a blood test

Researchers found that patients whose oropharyngeal cancer recurred had higher levels of antibodies for two proteins, E6 and E7, which are found in HPV-fueled cancers. The finding suggests a potential blood-based marker that could predict when cancer is likely to return.

Pages